It’s been about five years since the U.S. Food and Drug Administration approved Wegovy for chronic weight management, but semaglutide, the active ingredient in Ozempic and similar drugs, goes back ...

Popular GLP-1 weight-loss drugs are becoming much more affordable for millions of older adults starting Wednesday, July 1, as Medicare begins to cover them — for now. The Medicare GLP-1 Bridge is a ...

The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey from Gallup. That’s up from 8% in 2025 and 3% in 2024, according to the ...

NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name ...

A secret shopper survey conducted by researchers at Yale University and published this week in the Journal of the American Medical Association offers an alarming, if unsurprising, glimpse into the ...

Starting Wednesday, people on Medicare will be able to get weight loss drugs, including Wegovy and Zepbound, for $50 a month. But patients hoping for quick or permanent access to the drugs may be ...

A Medicare pilot has broadened access to medications like Wegovy and Zepbound. There are unique risks for those over 65. By Dani Blum See more of our coverage in your search results.Encuentra más de ...

What Are GLP-1 Drugs? Injectable GLP-1 (glucagon-like peptide-1) receptor agonists were first introduced for managing Type 2 diabetes, a condition that affects over a quarter of Medicare beneficiaries ...

Lower-cost generic versions of GLP-1 drugs used to treat obesity and Type 2 diabetes have moved a step closer to reality after Swiss drugmaker Sandoz cleared an early regulatory hurdle with the U.S.

The postal worker mom who was kidnapped and murdered on her mail route was a convicted drug dealer — as was her husband, who died just months before her, according to court records Brandi Reynolds, 35 ...